Cargando…
Optochemical Control of Therapeutic Agents through Photocatalyzed Isomerization
A Ru(bpy)(3)Cl(2) photocatalyst is applied to the rapid trans to cis isomerization of a range of alkene‐containing pharmacological agents, including combretastatin A‐4 (CA‐4), a clinical candidate in oncology, and resveratrol derivatives, switching their configuration from inactive substances to pot...
Autores principales: | Watson, Emma E., Russo, Francesco, Moreau, Dimitri, Winssinger, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400970/ https://www.ncbi.nlm.nih.gov/pubmed/35510306 http://dx.doi.org/10.1002/anie.202203390 |
Ejemplares similares
-
Control of Protein Function through Optochemical Translocation
por: Engelke, Hanna, et al.
Publicado: (2014) -
Optochemical control of RNA interference in mammalian cells
por: Govan, Jeane M., et al.
Publicado: (2013) -
In vivo optochemical control of cell contractility at single‐cell resolution
por: Kong, Deqing, et al.
Publicado: (2019) -
In situ monitoring of photocatalyzed isomerization reactions on a microchip flow reactor by IR-MALDI ion mobility spectrometry
por: Prüfert, Chris, et al.
Publicado: (2020) -
Photocatalyzed cycloaromatization of vinylsilanes with arylsulfonylazides
por: Chen, Fengjuan, et al.
Publicado: (2021)